Dmitry Klimenko
send message
Education
| ||
Experience
| ||
Languages
|
| ||
- “Protecting biopharmaceutical inventions in Russia and Eurasia” (IAM Life Scienses 2017)
- “Crystallization and preliminary
X-ray crystallographic studies of RepDC, a hybridrolling-circle plasmid replication initiator protein” (“Acta Crystallographica Section D: Biological Crystallography”, 1999 (co-authors Convery M.A., Rowsell S., Thomas C.D., Phillips S.E.) - “DNA mobility in crystals of a nonspecific lambda cro/DNA complex” (Journal of Biomolecular Structure & Dynamics, 1995 (
co-authors Chernov B.K., Malinina L.V.)
Presentations
- “Vaccines and IP Protection – A Profit and Loss Statement for Companies?”, (World IP Forum, Bengaluru, January 2024)
- “Russia is Your Business Partner”, (15th Global IP Convention, Delhi, January 2024)
- “Protection of Innovations in Biotechnology: Inventions and Breeding Achievements” (10th Russian Biotechnology Forum OpenBio-2023, Novosibirsk, September 2023)
- “Pandemics and Vaccines. A Patent View” (Webinar “Pandemics and Vaccines. A Patent View”, Moscow, June 2021)
- “Enforceability and infringement of second medical use claims” (The MIP International Patent Forum 2019, London, March 2019)
- “Pharma Patent extension” (BRICS IP Forum 2017, Paris, October 2017)
- “Extending patent terms Russia and CIS” (16th C5’s Pharma Patent Extensions Forum, Munich, May 2017)
- “Enforcing Patents in Russia and CIS” (15th International Forum on Pharmaceutical Patent Term Extensions, Munich, June 2016)
- “Patent protection strategies in Russia” (“MIP Global IP & Innovation Summit 2014”, Shanghai, China, September 2014)
- “Patenting pharmaceutical inventions in Russia and Eurasia” (Sweden, October 2013)
- “Legal issues on protection and enforcement of IP rights in Russia” (seminar “Update on Biopharma IP Issues in Growth Markets: Russia, China, India, Korea & Brazil”, New Jersey Intellectual Property Law Association (NJIPLA) and Association of Corporate Counsel (NJCCA), New York, USA, May 2013)
- “What route to choose for biotech patents in Russia: NATIONAL OR EURASIAN?” (8th Annual seminar “Obtaining and Enforcement of Intellectual Property Rights in Russia”, Moscow, September 2012)
- Consulting foreign and Russian companies and research institutes on a patenting strategy issues in Russia, USA, European Union countries, CIS countries, China and Hong Kong.